Tiziana Life Sciences Ltd (TLSA)

NASDAQ: TLSA · Real-Time Price · USD

1.500

-0.070 (-4.46%)

At close: May 12, 2025, 4:00 PM

1.530

+0.030 (2.00%)

After-hours: May 12, 2025, 4:39 PM EDT

Tiziana Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	10.57	9.87	1.63	14.17	24.42	Upgrade
Research & Development	5.23	8.11	12.96	13.21	5.99	Upgrade
Operating Expenses	15.79	17.98	14.59	27.37	30.41	Upgrade
Operating Income	-15.79	-17.98	-14.59	-27.37	-30.41	Upgrade
Interest Expense	-	-0.01	-0.01	-0.18	-0.32	Upgrade
Interest & Investment Income	-	1.15	0.03	-	0.01	Upgrade
Other Non Operating Income (Expenses)	0.81	-	0.03	0.89	-	Upgrade
EBT Excluding Unusual Items	-14.98	-16.84	-14.53	-26.66	-30.72	Upgrade
Gain (Loss) on Sale of Investments	-1.77	-0.4	-0.87	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	2.66	Upgrade
Asset Writedown	-	-	-	-	-0.28	Upgrade
Pretax Income	-16.75	-17.24	-15.4	-26.66	-28.34	Upgrade
Income Tax Expense	-4.88	0.45	-	-3.24	-2.21	Upgrade
Net Income	-11.86	-17.69	-15.4	-23.42	-26.13	Upgrade
Net Income to Common	-11.86	-17.69	-15.4	-23.42	-26.13	Upgrade
Shares Outstanding (Basic)	108	102	102	98	97	Upgrade
Shares Outstanding (Diluted)	108	102	102	98	97	Upgrade
Shares Change (YoY)	5.24%	0.93%	3.67%	0.64%	-	Upgrade
EPS (Basic)	-0.11	-0.17	-0.15	-0.24	-0.27	Upgrade
EPS (Diluted)	-0.11	-0.17	-0.15	-0.24	-0.27	Upgrade
Free Cash Flow	-1.55	-15.7	-19.62	-21.78	-11.34	Upgrade
Free Cash Flow Per Share	-0.01	-0.15	-0.19	-0.22	-0.12	Upgrade
EBITDA	-15.78	-17.98	-14.59	-27.37	-30.41	Upgrade
D&A For EBITDA	0.01	0.01	0	0.01	0.01	Upgrade
EBIT	-15.79	-17.98	-14.59	-27.37	-30.41	Upgrade

Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q